[{"Assets_0_Q3_USD":1222500000.0,"CIK":"1737287","CommonStockSharesConverted_0_Q3_shares":139755839.0,"CommonStockSharesOutstanding_0_Q3_shares":139755839.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.52,"EarningsPerShareBasic_3_Q3_USD":-1.55,"Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-105118000.0,"NetIncomeLossConverted_1_Q3_USD":-66197000.0,"NetIncomeLossConverted_3_Q3_USD":-181651000.0,"OfficialName":"Allogene Therapeutics Inc. Common Stock","SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":1118731000.0,"Ticker":"ALLO","filed":"20201104","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2020.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20200930","qtrs":"3","uom":"USD"}]